Year | Citation | Score | |||
---|---|---|---|---|---|
2024 | Ponserre M, Ionescu TM, Franz AA, Deiana S, Schuelert N, Lamla T, Williams RH, Wotjak CT, Hobson S, Dine J, Omrani A. Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction. Neuropharmacology. 109970. PMID 38685343 DOI: 10.1016/j.neuropharm.2024.109970 | 0.34 | |||
2022 | Latuske P, von Heimendahl M, Deiana S, Wotjak CT, du Hoffmann J. Sustained MK-801 induced deficit in a novel probabilistic reversal learning task. Frontiers in Pharmacology. 13: 898548. PMID 36313373 DOI: 10.3389/fphar.2022.898548 | 0.316 | |||
2022 | Deiana S, Hauber W, Munster A, Sommer S, Ferger B, Marti A, Schmid B, Dorner-Ciossek C, Rosenbrock H. Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodents. European Journal of Pharmacology. 175306. PMID 36183855 DOI: 10.1016/j.ejphar.2022.175306 | 0.429 | |||
2015 | Deiana S, Watanabe A, Yamasaki Y, Amada N, Kikuchi T, Stott C, Riedel G. MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol. Behavioural Pharmacology. 26: 748-65. PMID 26287433 DOI: 10.1097/Fbp.0000000000000178 | 0.304 | |||
2009 | Deiana S, Harrington CR, Wischik CM, Riedel G. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology. 202: 53-65. PMID 19005644 DOI: 10.1007/S00213-008-1394-2 | 0.309 | |||
Show low-probability matches. |